Will AstraZeneca turn, or will it continue to rise to 6523p highs (+4.8%)?

• Shares +8.1% from recent lows; Now trading 6219p (at the time of writing).
• Will the positive momentum continue towards 6523p (+4.8%)?
• Shares -4.9% from 2019 highs; +17.1% from 2019 lows; +5.9% year-to-date.
• 14 Jun: LOKELMA showed efficacy vs Hyperkalemia in patients with end-stage Renal disease on Hemodialysis
• 10 Jun: FARXIGA showed reduced Kidney Disease or Renal Death in Patients With Type 2 Diabetes
• Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal

Click to enlarge

Trading AstraZeneca – An Example

Let’s say the trend appeals to you, you think it’s likely to continue. You decide to buy exposure to £10,000 worth of AstraZeneca using a CFD, at the current price of 6219p. To do this, you need £2,000.

Let’s assume the AstraZeneca trend continues to 6523p Jan highs (+4.8%). Your profit would be £480, from your initial investment of £2,000.

Conversely, let’s assume you open the above position, and place a stop-loss at 2% from the current price. AstraZeneca falls 2% and hits your stop-loss. Your loss would be £200.

This is provided for information purposes only. It should not be taken as a recommendation.